Apogee Therapeutics, Inc. 10-Q filing
Filed 2025-08-11 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-106234
- Form type
- 10-Q
- CIK
- 0001974640
- Primary document
- https://www.sec.gov/Archives/edgar/data/1974640/000095017025106234/apge-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Apogee Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-136.3M | - | - |
| Net Income | $-121.4M | - | - |
| Eps Basic | -2.08 | - | - |
| Eps Diluted | -2.08 | - | - |
| Cash And Equivalents | $124.2M | - | - |
| Total Assets | $657.8M | - | - |
| Total Liabilities | $38.4M | - | - |
| Operating Cash Flow | $-110.5M | - | - |
| Capital Expenditures | $5.1M | - | - |